Animal Blood
- Response deadline
- Sep 18, 2026 Due in 2 days
- Date posted
- Sep 16, 2026
- Source
- Open notice
Description
This is a synopsis of a procurement for commercial products prepared in accordance with the commercial acquisition procedures of RFO Part 12. Solicitation No. 75F40126Q00362 was issued as a Request for Quotation (RFQ) for donor animal whole blood (bovine, ovine, and porcine) for the FDA Center for Devices and Radiological Health (CDRH), Office of Science and Engineering Laboratories (OSEL), Cardiovascular Program, Division of Applied Mechanics (DAM). The blood products support blood compatibility (hemocompatibility) testing and medical device research, including hemolysis- and thrombosis-related projects, as further described in Attachment 1 – Requirements Document. All supplies shall meet the minimum requirements in Attachment 1 – Requirements Document, including species availability, minimum draw frequency, blood quality, minimum delivery volumes, anticoagulant type, labeling, quarantine protocol, veterinary oversight, AAALAC accreditation, and ISO 13485:2016 certification.
Classifications
Documents (1)
- Animal_Whole_Blood_Combined_Synopsis.pdf.pdf154 KBNot yet available
Contacts
- erika.crawford@fda.hhs.gov3017960298
Similar contracts
- Lonza – Cryopreserved Primary Human Hepatocytes (spheroid-qualified)North CarolinaDue Sep 21, 2026
- 2027 Southern Hemisphere Influenza VaccineDue Sep 30, 2026
- Methylation Sequencing Library Preparation Kits foDue Sep 14, 2026
- Vivo Efficacy of Blood stable Thiobenzamides MarylandDue Sep 20, 2026
- Notice of Intent: Chromium GEM-X sequencing reagentsMarylandDue Sep 10, 2026
- Acquisition of an Agilent-BioTek Multimode Plate ReaderMarylandDue Sep 6, 2026